The evaluation of effectiveness of dT vaccine on immune response to HB vaccine in non responder dialysis patients
Phase 2
- Conditions
- End Stage Renal Disease.ESRD
- Registration Number
- IRCT138812093454N1
- Lead Sponsor
- Isfahan University Of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Inclusion:1)age>=18yr,2)hemodialysis and peritoneal dialysis patients,3)comleted at least 3 dose HBV vaccine schedule and had HBS Ab <10
Exclusion:1)no compliance,2)renal transplant
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HBS Ab titer. Timepoint: 1-2 m and 6 month after completing vaccination. Method of measurement: ELISA.
- Secondary Outcome Measures
Name Time Method --------. Timepoint: -----. Method of measurement: ------.